Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong-Reference-Cited by-同舟云学术

Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong

Published:2017-10-04 Issue:1 Volume:84 Page:172-178
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Ching Chor Kwan¹^ORCID,Chen Sammy Pak Lam¹,Lee Hencher Han Chih¹,Lam Ying Hoo¹,Ng Sau Wah¹,Chen Mo Lung¹,Tang Magdalene Huen Yin¹,Chan Suzanne Suk San¹,Ng Candy Wai Yan¹,Cheung Jana Wing Lan¹,Chan Tina Yee Ching¹,Lau Nike Kwai Cheung¹,Chong Yeow Kuan¹,Mak Tony Wing Lai¹

Affiliation:

1. Hospital Authority Toxicology Reference Laboratory; Princess Margaret Hospital; Hong Kong

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13420/fullpdf

Reference16 articles.

1. Thematic household survey report no. 58 2015

2. Traditional Chinese medicine: a report by the committee on traditional Chinese medicine 1995

3. Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan;Huang;J Clin Pharmacol,1997